(Q77839223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Utilization of BRCA1/2 genetic testing in the clinical setting: report from a single institution (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Soo-Chin Lee

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Barbara A Bernhardt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Kathy J Helzlsouer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1876-1885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Interest in genetic testing among first-degree relatives of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Attitudes about genetic testing for breast-ovarian cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Attitudes towards cancer predictive testing and transmission of information to the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Genetic testing for breast-ovarian cancer susceptibility: a regional trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Hereditary cancer risk notification and testing: how interested is the general population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Women's receptivity to testing for a genetic susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10420

21 January 2018

Identifiers

DOI

10.1002/CNCR.10420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920551%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference